Deep Tide TechFlow news, on August 5th, according to BusinessWire, the American pharmaceutical company MEI Pharma (NASDAQ: MEIP) announced the acquisition of 929,548 Litecoins (LTC) at an average purchase price of $107.58, with a total value of approximately $110 million. The company becomes the first publicly listed company in the United States to use Litecoin as a primary reserve asset.

Earlier news, MEI Pharma completed a $100 million private placement, incorporating Litecoin into its financial reserves.